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Abstract
Background: Intestinal colonization by Staphylococcus aureus among hospitalized patients has been
associated with increased risk of staphylococcal infection and could potentially contribute to
transmission. We hypothesized that S. aureus intestinal colonization is associated with increased
frequency of S. aureus on patients' skin and nearby environmental surfaces.
Methods: Selected inpatients were cultured weekly for S. aureus from stool, nares, skin (groin and
axilla), and environmental surfaces (bed rail and bedside table). Investigator's hands were cultured
after contacting the patients' skin and the environmental surfaces.
Results: Of 71 subjects, 32 (45.1%) had negative nares and stool cultures, 23 (32.4%) had positive
nares and stool cultures, 13 (18.3%) were nares carriers only, and 3 (4.2%) were stool carriers only.
Of the 39 patients with S. aureus carriage, 30 (76.9%) had methicillin-resistant isolates. In
comparison to nares colonization only, nares and intestinal colonization was associated with
increased frequency of positive skin cultures (41% versus 77%; p = 0.001) and trends toward
increased environmental contamination (45% versus 62%; p = 0.188) and acquisition on
investigator's hands (36% versus 60%; p = 0.057). Patients with negative nares and stool cultures
had low frequency of S. aureus on skin and the environment (4.8% and 11.3%, respectively).
Conclusion: We found that hospitalized patients with S. aureus nares and/or stool carriage
frequently had S. aureus on their skin and on nearby environmental surfaces. S. aureus intestinal
colonization was associated with increased frequency of positive skin cultures, which could
potentially facilitate staphylococcal infections and nosocomial transmission.
Background
Staphylococcus aureus is an important cause of community-
acquired and healthcare-associated infections [1]. The
nose (anterior nares) is considered the primary site of col-
onization with S. aureus; however, several recent studies
suggest that colonization of the intestinal tracts of hospi-
talized patients may have important clinical implications
[2-4]. We found that more than half of patients with van-
comycin-resistant  Enterococcus  (VRE) stool colonization
had coexisting intestinal colonization with S. aureus, pro-
viding a potential reservoir for the emergence vancomy-
cin-resistant S. aureus isolates [2]. Boyce et al. [3] and
Gravet et al. [4] have suggested that enterotoxin-produc-
ing methicillin-resistant S. aureus (MRSA) strains may be
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an underappreciated cause of antibiotic-associated
diarrhea. Finally, Squier et al. [5] found that intensive care
and liver transplant unit patients with both rectal and
nares MRSA colonization had significantly higher rates of
S. aureus infection than did patients with nares carriage
alone (40% vs. 18%).
The mechanism by which intestinal colonization by S.
aureus might lead to an increased risk of staphylococcal
infections is not known. Squier et al. [5] proposed that
intestinal colonization by S. aureus could be associated
with increased frequency of colonization or contamina-
tion of skin sites, thereby increasing the risk for contami-
nation of devices, wounds, and mucous membranes. In
addition to facilitating infections, shedding of large
number of S. aureus from stool onto skin and environ-
mental surfaces could potentially contribute to nosoco-
mial transmission [5-7]. Other explanations for the
association between intestinal colonization with S. aureus
and infections are also possible. For example, strains with
increased virulence might have a greater propensity to col-
onize the intestinal tract or the skin. We performed a pro-
spective observational study to test the hypothesis that
intestinal colonization by S. aureus is associated with
increased frequency of positive skin cultures and
increased contamination of nearby environmental sur-
faces.
Methods
Setting and study design
We performed a 6-month prospective study of selected
inpatients at the Cleveland Veterans Affairs Medical
Center. Subjects were selected by reviewing in sequence a
listing of all inpatients hospitalized on the first workday
of each week; the list was generated based on time of
admission. Patients with an anticipated duration of addi-
tional stay in the hospital of less than 3 days were
excluded in order to allow for collection of serial samples
from a significant proportion of the subjects. After oral
informed consent was obtained, stool samples were col-
lected each week during the admission. Stool samples
were refrigerated at 4°C and either processed within one
week, or frozen at (-) 80°C for analysis at a later date. We
tested for the presence of S. aureus in stool specimens, and
if present, determined the density of colonization.
Patients were considered to have persistent stool or nares
colonization if S. aureus was cultured from three or more
consecutive stool or nares samples, respectively.
Within 1 day of each stool collection, cultures were
obtained from the patient's anterior nares, skin (groin and
axilla), and environment (bed rail and bedside table)
using pre-moistened cotton-tipped swabs. In addition,
hand imprint cultures for S. aureus were obtained after
contacting the same skin and environment sites noted
above as described previously [8]. In short, the investiga-
tors disinfected their hands with 62.5% alcohol hand rub
and imprinted 1 hand onto a mannitol salt agar (Becton
Dickinson, Cockeysville, MD) plate to confirm that no S.
aureus  were present. The same hand was then placed
sequentially onto the patient's bedrail, bedside table,
groin, and axilla, each for 5 seconds. The fingertips and
palms were then imprinted onto a second mannitol salt
agar plate and processed as described below.
Information regarding demographic characteristics, coex-
isting illnesses, S. aureus infections, and medications and
treatments was obtained through standardized medical
record review. All subjects were assessed for development
of S. aureus infections during their admissions and charts
were reviewed to evaluate whether infections occurred
within 90 days after discharge. Because some antibiotics
have in vitro inhibitory activity against S. aureus strains,
we assessed whether therapy with antibiotics with in vitro
activity against the colonizing strains was associated with
elimination of nares or intestinal carriage. Infections were
defined using the Centers for Disease Control and Preven-
tion criteria for nosocomial infections [9]. The Louis
Stokes Cleveland Department of Veterans Affairs Medical
Center's Institutional Review Board approved the study
protocol.
Microbiologic analysis and molecular typing
In order to screen for the presence of S. aureus, samples
were plated onto mannitol salt agar (Becton Dickinson).
Plates were incubated at 37°C for 48 hours and colonies
consistent with S. aureus were subjected to identification
and susceptibility testing in accordance with National
Committee for Clinical Laboratory Standards guidelines
[10]. The density of organisms/g of stool was determined
as previously described [2]. If no organisms were detected,
the lower limit of detection was assigned (~1.5 log/g). The
number of colonies of S. aureus from cultures of nares,
skin, environmental surfaces, and investigator's hands
were counted. Pulsed-field gel electrophoresis was per-
formed on selected S. aureus isolates using a modification
of the technique of Hoyen et al [11]. The plugs were
digested with SmaI for 16 hours (Promega, Madison,
Wis.). Pulsed-field gel patterns were interpreted using the
criteria of Tenover et al [12].
Statistical analysis
Data were analyzed using SPSS version 10.0 (Chicago, IL).
We compared the characteristics of 3 groups (i.e., stool
colonization with or without concurrent nares coloniza-
tion, nares colonization only, and no colonization as evi-
denced by negative nares and stool cultures). Patients
with positive stool cultures but negative nares cultures
were not analyzed separately for differences in patient
characteristics because there were only 3 subjects in thisBMC Infectious Diseases 2007, 7:105 http://www.biomedcentral.com/1471-2334/7/105
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group. One-way analysis of variance was used for analysis
of continuous variables and the Pearson Chi-square test or
Fisher's exact test was used for analysis of categorical data.
Additional bi-variate analyses were performed to compare
characteristics of patients with any S. aureus colonization
of nares or stool to those with no colonization (i.e., nega-
tive nares and stool cultures), and to compare colonized
patients with stool carriage (with or without concurrent
nares carriage) to patients with nares colonization only.
For purposes of analysis, patients with a positive nares or
stool culture at any time during the study were considered
to be positive at these sites. The frequencies of positive
cultures for skin, environment, and hand acquisition cul-
tures were analyzed using the Pearson Chi-square test or
Fisher's exact test. All reported p values are two-sided.
Unless otherwise stated, mean values are given as means
± SD. Finally, the impact of antibiotic treatment was
examined to determine whether antibiotics with in vitro
activity against colonizing S. aureus strains would inhibit
nares or intestinal colonization.
Results
Characteristics of the patients
Seventy-one total patients were enrolled in the study.
Thirty-two (45.1%) patients had negative nares and stool
cultures for S. aureus; 23 (32.4%) had positive nares and
stool cultures; 13 (18.3%) had positive nares but negative
stool cultures; and 3 (4.2%) had negative nares but posi-
tive stool cultures. Of the 39 patients with S. aureus colo-
nization, 30 (76.9%) had MRSA. Of the 23 patients with
nares and intestinal colonization, 18 (78.3%) had 3 sets
of cultures obtained and 100% had persistent positive
stool and nares cultures (i.e. positive cultures from 3 con-
secutive cultures). The mean density of S. aureus in stool
of these patients was 4.39 log/g of stool (range, 1.5 to 7.4
log/g). Fifteen of the 18 patients with persistent positive
stool cultures maintained S. aureus colonization for the
duration of their admission and/or participation in the
study (range, 3 to 22 weeks). Five of the 13 patients with
positive nares but negative stool cultures had 3 consecu-
tive sets of cultures, and 4 of 5 (80%) had persistent pos-
itive nares cultures.
When patients with stool carriage (with or without con-
current nares carriage), nares carriage only, and no stool
or nares carriage were compared (Table 1), only the devel-
opment of S. aureus infections was significantly different
among the 3 groups. When patients with any S. aureus col-
onization were compared to those with no stool or nares
carriage, those with S. aureus colonization were more
likely to have diarrhea or fecal incontinence (59.0% ver-
sus 25.0%; p = 0.02), S. aureus infection (25.6% versus
Table 1: Characteristics of the 71 study patients and events during the study Staphylococcus aureus colonization sites
Stool +
Nares +/-
Nares
only
Nares -
Stool -
Characteristic (N = 26) (N = 13) (N = 32) p*
At baseline
Age, years, mean ± SD 65.0 ± 14.5 66.1 ± 11.4 63.1 ± 13.2 0.76
Length of stay, mean ± SD 22.6 ± 18.6 19.2 ± 16.1 13.2 ± 12.1 0.13
Male sex, no. (%) 26 (100) 13 (100) 32 (100) 1
Clinical conditions, no. (%)
Chronic renal failure 3 (11.5) 2 (15.4) 2 (6.3) 0.61
Diabetes mellitus 9 (34.6) 4 (30.8) 12 (37.5) 0.91
Chronic dermatologic conditions 1 (3.8) 1 (7.7) 1 (3.1) 0.25
Wounds 11 (42.3) 4 (30.8) 6 (18.8) 0.15
Liver disease 4 (15.4) 1 (7.7) 1 (3.1) 0.25
Cancer 5 (19.2) 0 (0) 7 (21.9) 0.19
Nursing home resident, no. (%) 4 (15.4) 3 (23.1) 5 (15.6) 0.81
During the study, no. (%)
Admission to intensive care unit 4 (15.4 1 (7.7) 2 (6.3) 0.13
Nasogastric tube 6 (23.1) 2 (15.4) 3 (9.4) 0.36
Mechanical ventilation 6 (23.1) 1 (7.7) 2 (6.3) 0.13
Antibiotic therapy 18 (69.2) 9 (69.2) 21 (65.6) 0.95
Vancomycin-resistant Enterococcus colonization 10 (38.5) 4 (30.8) 7 (21.9) 0.39
Central venous catheter 5 (19.2) 1 (7.7) 6 (18.8) 0.62
Diarrhea or fecal incontinence 15 (57.7) 8 (61.5) 8 (25) 0.06
Surgery 4 (15.4) 2 (15.4) 6 (18.8) 0.93
Proton pump inhibitor or H2 blocker 18 (69.2) 9 (69.2) 21 (65.6) 0.95
S. aureus infection 8 (30.8) 2 (15.4) 1 (3.1) 0.02
*p values refer to overall differences among the 3 groupsBMC Infectious Diseases 2007, 7:105 http://www.biomedcentral.com/1471-2334/7/105
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3.1%; P = 0.009), and increased length of stay (21.5 ± 17.7
versus 13.2 ± 12.1; p = 0.02); there was a trend toward
increased frequency of wounds in patients with any S.
aureus colonization versus those with no carriage (38.5%
versus 18.8%; p = 0.07). Patients with stool carriage (with
or without concurrent nares carriage) did not differ signif-
icantly from patients with nares carriage only in any of the
variables assessed.
Overall, 15.5% of the study patients (11 of 71) developed
S. aureus infections. These included bacteremia in 5
patients, empyema in 1, pneumonia in 3, and wound
infection in 2. S. aureus infection occurred in 30.4% of
patients with nares and stool colonization (7 of 23),
15.4% of patients with nares colonization only (2 of 13),
33.3% of patients with stool colonization only (1 of 3),
and in 3.1% of those with no stool or nares colonization
(1 of 32). S. aureus infection developed more often in
patients with stool colonization (8/26; 30.8%) versus
those with only nares colonization (2/13; 15.4%) but the
difference was not statistically significant (p = 0.30).
Contamination of skin, environment, and hands with S. 
aureus
A total of 138 sets of cultures were obtained (mean, 1.9
per patient; range, 1 to 6). Figure 1 provides a summary of
the results. Patients with S. aureus nares and intestinal col-
onization or nares colonization only were more likely to
have positive cultures of skin and environment than
patients who had negative nares and stool cultures (p <
0.001), and investigators were more likely to acquire S.
aureus on hands after contacting skin and environmental
surfaces of these patients (p < 0.001). Patients with nares
and intestinal colonization were more likely than those
with nares colonization only to have positive skin cultures
(p = 0.001). In comparison to patients with nares coloni-
zation only, patients with nares and intestinal coloniza-
tion also had non-significant trends toward increased S.
aureus  contamination of environmental surfaces (p =
0.188) and increased acquisition of S. aureus on investiga-
tor's hands (p = 0.057). Patients with negative nares but
positive stool cultures had trends toward higher rates of
skin, environment, and investigator hand cultures than
patients with negative cultures, but these differences were
not statistically significant (p ≥ 0.05). However, only 3
patients and 6 sets of cultures were included in this group,
providing relatively little power to determine if significant
differences were present. Among the patients with intesti-
nal colonization, the 15 subjects with fecal incontinence
or diarrhea had non-significant trends toward higher rates
of skin (75% versus 65.9%, respectively) and environ-
mental (59.1% versus 50%, respectively) contamination
than the 11 subjects with no fecal incontinence or
diarrhea (p ≥ 0.05).
Of the 138 sets of cultures, 61 (44.2%) sets obtained from
28 patients (39.4% of all patients) had positive skin cul-
tures. The axilla and groin sites were positive in 26 of the
61 (43%) sets of positive cultures, only the groin was pos-
itive in 32 of 61 (51.6%) sets, and only the axilla was pos-
itive in 3 (4.9%). The number of colonies of S. aureus
obtained from the groin and axilla was frequently too
numerous to count. Positive environmental cultures
yielded a mean of 12.7 colonies of S. aureus (range, 1 to
80). Positive investigator hand cultures after contact with
skin and environmental surfaces yielded a mean of 15.3
colonies of S. aureus (range, 1 to 80).
Effect of antibiotics with in vitro inhibitory activity against 
colonizing strains
Four patients with nares and intestinal S. aureus suscepti-
ble to vancomycin continued to have colonization of
both sites while receiving therapy with intravenous vanco-
mycin; a fifth patient from this group maintained stool
colonization with MRSA while receiving oral vancomycin
therapy for C. difficile infection (Figure 2A). One patient
with nares MRSA colonization only continued to have
positive nares cultures while receiving intravenous vanco-
mycin. One patient with nares and intestinal colonization
with a levofloxacin-susceptible MRSA isolate developed
negative cultures at both sites while receiving oral levo-
floxacin (Figure 2B). However, 5 patients colonized with
levofloxacin-resistant S. aureus isolates maintained per-
sistent nares and/or stool cultures during therapy with this
agent. No patients received therapy with other agents with
in vitro inhibitory activity against colonizing S. aureus
strains.
Molecular typing
For 8 study patients, pulsed-field gel electrophoresis was
performed on multiple S. aureus isolates. For 4 patients
with nares, stool, skin, and environmental isolates, the
nares, stool, and skin isolates of each patient were clonally
identical; environmental isolates from 3 of the 4 patients
were identical to isolates cultured from the other sites,
whereas an environmental isolate from the fourth patient
was unrelated to the isolates from the other sites. For 4
patients with nares, skin, and environmental isolates, the
skin isolates were identical (3 of 4 patients) or closely
related (1 of 4 patients) to the corresponding nares iso-
lates; environmental isolates from 2 of the 4 patients were
identical to isolates cultured from nares, whereas environ-
mental isolates of the other 2 patients were unrelated to
nares or skin isolates.
Discussion
In this prospective study, we found that two-thirds of hos-
pitalized patients harboring S. aureus had intestinal colo-
nization with these organisms. Of the 26 study patients
with S. aureus in stool, 20 (77%) had persistent stool car-BMC Infectious Diseases 2007, 7:105 http://www.biomedcentral.com/1471-2334/7/105
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riage and 23 (88%) had concurrent nares carriage. These
data are consistent with previous studies that have dem-
onstrated that S. aureus intestinal colonization is common
among hospitalized patients [2-5]. The major new finding
of our study was that patients with nares and intestinal S.
aureus  colonization were significantly more likely than
those with nares colonization only to have positive skin
cultures, and these subjects exhibited a non-significant
trend toward increased contamination of environmental
surfaces and of acquisition on investigator's hands after
contacting skin and environmental surfaces. Because sta-
phylococci on skin may contaminate devices or wounds
and be acquired on hands, our data provide support for
the hypothesis that colonization of the intestinal tract
may facilitate S. aureus infections and nosocomial trans-
mission.
As noted previously, Squier et al. [5] found that intensive
care and liver transplant unit patients with both rectal and
nares MRSA colonization had significantly higher rates of
S. aureus infection than did patients with nares carriage
alone (40% vs. 18%). We also found that patients with
nares and intestinal S. aureus colonization developed
infections about twice as often as those with nares coloni-
zation alone (30.8% versus 15.4%), but this difference
was not statistically significant. It should be noted, how-
ever, that the small numbers of subjects included in our
study provided limited power to distinguish between the
rates of infection in the 2 groups. Additional studies are
indicated to examine the association between S. aureus
intestinal colonization and the development of infec-
tions.
Previous studies suggest that factors such as decreased gas-
tric acidity, nasogastric tubes, and antibiotic therapy may
contribute to the development of intestinal colonization
by S. aureus [2,3,13]. We did not find a significant associ-
ation between these factors and S. aureus intestinal colo-
nization in our study. It is notable that more than half of
the patients with nares S. aureus colonization only
received treatment with proton pump inhibitors and anti-
biotics, suggesting that these factors alone may not be suf-
ficient for the development of intestinal colonization in
many patients with nares carriage. Because antibiotics
may also inhibit colonization by pathogens, we examined
the impact of treatment with agents with in vitro inhibi-
tory activity against S. aureus. Intravenous vancomycin
had no apparent effect on nares or intestinal S. aureus col-
onization, possibly due to the fact that relatively low con-
Effect of antibiotic therapy with agents with in vitro inhibitory  activity against colonizing methicillin-resistant Staphylococcus  aureus (MRSA) strains Figure 2
Effect of antibiotic therapy with agents with in vitro inhibitory 
activity against colonizing methicillin-resistant Staphylococcus 
aureus (MRSA) strains. One patient (A) received oral vanco-
mycin for treatment of Clostridium difficile-associated diarrhea 
and a second (B) received oral levofloxacin for treatment of a 
urinary tract infection. The minimum inhibitory concentra-
tion (MIC) of vancomycin for the MRSA isolate in A was 0.25 
µg/mL; the MIC of levofloxacin for the MRSA isolate in B was 
0.125 µg/mL). + = positive nares culture; - = negative nares 
culture; solid circles = density of MRSA in stool.
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centrations of this agent are secreted into nares passages or
into the intestinal tract during parenteral administration
[14]. In one patient, oral levofloxacin temporarily was
associated with loss of detection of nares and intestinal
colonization with a levofloxacin-susceptible MRSA strain;
levofloxacin therapy did not result in loss of colonization
by levofloxacin-resistant S. aureus strains.
Two recent European studies have evaluated the use of
oral vancomycin therapy as a means to eliminate MRSA
intestinal colonization [15,16]. In one study, oral vanco-
mycin therapy was associated with a significant reduction
in methicillin-resistant S. aureus infections [15]. Interest-
ingly, one patient in our study maintained intestinal col-
onization with MRSA during therapy with oral
vancomycin (Figure 2A), which results in high concentra-
tions in the colon. In mice, we found that intestinal colo-
nization with 1 of 2 MRSA strains also was not inhibited
by oral vancomycin; we hypothesized that such persist-
ence might be due to growth of MRSA within a biofilm in
the colonic mucus layer [13]. Further studies are needed
to clarify the potential for eradication of intestinal S.
aureus colonization with oral non-absorbed antibiotics.
Our study has several limitations. First, our study popula-
tion may not be representative of all patient populations
because only men were included and we excluded patients
with an anticipated additional length of hospital stay of
less than 3 days. Second, 15 of 26 (58%) patients with
intestinal  S. aureus colonization had diarrhea or fecal
incontinence during the period of the study which is likely
to have contributed to shedding of organisms onto skin
and into the environment. It is possible that continent
patients with no diarrhea may be less likely to shed S.
aureus, and we observed a trend toward lower rates of skin
and environmental S. aureus among these patients in
comparison to patients with fecal incontinence or
diarrhea. Third, hand cultures were obtained after contact
with both skin and environmental sites, and therefore it is
not possible to determine the relative contribution of skin
or the environment to hand acquisition. Fourth, S. aureus
isolates cultured from surfaces may have been shed by
previous patients occupying the study patient's rooms
because staphylococci may persist for long periods on sur-
faces. The fact that some environmental isolates were
clonally unrelated to the study patient's nares and stool
isolates suggests that contamination may have come from
previous room occupants or from hands of transiently
colonized healthcare workers, or that patient and environ-
mental cultures may be polyclonal in nature. Fifth, Boyce
et al. [17] found that the presence of MRSA in wounds or
urine was associated with increased environmental con-
tamination. In our study, there was a non-significant
trend toward increased frequency of wounds in patients
with stool and/or nares colonization than those with
nares colonization only (42.3% versus 30.8%); however,
the frequency of wounds from which S. aureus was iso-
lated from clinical cultures was similar in both groups (7
of 26 {26.9%} and 3 of 13 {23.1%}), respectively.
Finally, although we propose that the increased isolation
of S. aureus from skin of patients with intestinal coloniza-
tion was attributable to fecal contamination, it is possible
that strains with an increased propensity to colonize the
intestinal tract also have an increased tendency to colo-
nize or contaminate skin.
Conclusion
We found that hospitalized patients with S. aureus carriage
had high rates of positive skin cultures and of contamina-
tion of environmental surfaces. Patients with nares and
intestinal S. aureus colonization were significantly more
likely than those with nares colonization only to have
positive skin cultures, and these subjects exhibited a non-
significant trend toward increased contamination of envi-
ronmental surfaces and of acquisition on investigator's
hands after contacting skin and environmental surfaces.
Further research is needed to better define the significance
of intestinal colonization with staphylococci with regard
to the pathogenesis of S. aureus infections and nosoco-
mial transmission.
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